This topic contains a solution. Click here to go to the answer

Author Question: Puckett Corp. has just issued nonconvertible preferred stock (cumulative) with a par value of 50 and ... (Read 64 times)

lidoalex

  • Hero Member
  • *****
  • Posts: 538
Puckett Corp. has just issued nonconvertible preferred stock (cumulative) with a par value of 50 and an annual dividend rate of 7.25. The preferred stock is currently selling for 38.75 per share. What is the yield or return (r) on this preferred stock?
 
  A) 9.341
  B) 9.345
  C) 9.351
  D) 9.355

Question 2

Which of the following statements is FALSE?
 
  A) Preferred stock usually has a stated or par value but unlike bonds, this par value is not repaid at maturity because preferred stocks do not have a maturity date.
  B) The only time the par value of preferred stock would be paid to the shareholder is if the company ceases operations or retires the preferred stock.
  C) Skipped preferred dividends become a liability of the company.
  D) Preferred stock cannot be converted into common stock.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ryrychapman11

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: D
Explanation: D) We first determine the annual dividend by multiplying the par value by the dividend rate. We have: 50  0.0725 = 3.625. Now, using the equation r = and dividing the 3.625 annual dividend by the current price of 38.75, we have: r = 0.093548, or about 9.355.

Answer to Question 2

Answer: D
Explanation: D) Preferred stock can be converted into common stock at a preset point in the future.





 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

For a complete list of videos, visit our video library